Watson-Marlow Fluid Technology Group (WMFTG), a manufacturer of peristaltic pumps and associated fluid handling technologies, has acquired Asepco through its parent company Spirax-Sarco Engineering plc, for £7.0 million. Asepco, based in California, specializes in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.
Asepco joins a product range comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Alitea OEM Pumps, MasoSine Process Pumps and Bredel Hose Pumps.
"The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow's position in the biopharmaceutical market,” Jay Whalen, President of the Watson-Marlow Fluid Technology Group, said in a press release. “This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise.”
Asepco's president, Steve Joy, will remain in his role.